Growing community of inventors

Westerly, RI, United States of America

Daniel Copley Schmitt

Average Co-Inventor Count = 13.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Daniel Copley SchmittMark E Schnute (3 patents)Daniel Copley SchmittAtli Thorarensen (3 patents)Daniel Copley SchmittRayomand Jal Unwalla (3 patents)Daniel Copley SchmittJohn Isidro Trujillo (3 patents)Daniel Copley SchmittBrian Stephen Gerstenberger (3 patents)Daniel Copley SchmittDaniel Wei-Shung Kung (3 patents)Daniel Copley SchmittAndrew Christopher Flick (3 patents)Daniel Copley SchmittRalph Pelton Robinson, Jr (3 patents)Daniel Copley SchmittPhilippe Marcel Nuhant (3 patents)Daniel Copley SchmittVincent Michael Lombardo (3 patents)Daniel Copley SchmittHuixian Wu (3 patents)Daniel Copley SchmittJames John Mousseau (3 patents)Daniel Copley SchmittDaniel Copley Schmitt (3 patents)Mark E SchnuteMark E Schnute (26 patents)Atli ThorarensenAtli Thorarensen (26 patents)Rayomand Jal UnwallaRayomand Jal Unwalla (25 patents)John Isidro TrujilloJohn Isidro Trujillo (23 patents)Brian Stephen GerstenbergerBrian Stephen Gerstenberger (14 patents)Daniel Wei-Shung KungDaniel Wei-Shung Kung (11 patents)Andrew Christopher FlickAndrew Christopher Flick (9 patents)Ralph Pelton Robinson, JrRalph Pelton Robinson, Jr (9 patents)Philippe Marcel NuhantPhilippe Marcel Nuhant (6 patents)Vincent Michael LombardoVincent Michael Lombardo (3 patents)Huixian WuHuixian Wu (3 patents)James John MousseauJames John Mousseau (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Pfizer Corporation (3 from 4,455 patents)


3 patents:

1. 12312344 - N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors

2. 11708360 - N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors

3. 10975065 - N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…